share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

SEC announcement ·  May 4 04:28
Summary by Futu AI
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Bruce I. Sachs to the issuer was not specified, and the table containing non-derivative securities information was left empty. Without these details, the impact of the transaction on Sachs' holdings and the overall market position of Vertex Pharmaceuticals remains unclear.
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Bruce I. Sachs to the issuer was not specified, and the table containing non-derivative securities information was left empty. Without these details, the impact of the transaction on Sachs' holdings and the overall market position of Vertex Pharmaceuticals remains unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.